loader
Please Wait
Applying Filters...

Seqens Seqens

X

Information, Expiry & Status of Health Canada Patents covering Dolutegravir.

Client Email Product
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 GlaxoSmithKline Inc. (1)

filter

01 2606282 (1)

filter

01 DOLUTEGRAVIR SODIUM (1)

filter

01 TABLET (1)

filter

01 2026-04-28 (1)

URL Supplier Web Content
2606282
50 mg
TABLET
Human
2026-04-28
2016-04-26
2006-04-28
TIVICAY
ORAL
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY